Wang Z - Search Results

1

[Classification and regression tree analysis of clinical patterns to predict the survival of patients with advanced non-small cell lung cancer treated with erlotinib].

Liu Y, Guo J, Wang Y, Yang J, Wang Z. Liu Y, et al. Among authors: wang z, wang y. Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):785-9. doi: 10.3779/j.issn.1009-3419.2011.10.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22008108 Free PMC article. Chinese.

2

[Inflammatory breast cancer: 38 cases clinical report].

Huang J, Zhang P, Liu P, Ou GF, Wang ZP, Xu BH. Huang J, et al. Ai Zheng. 2002 Aug;21(8):888-91. Ai Zheng. 2002. PMID: 12478900 Chinese.

3

[Docetaxel in the treatment of advanced breast cancer ].

Wang ZP, Sun Y, Zhang XR, Zhang MH, Wang XW, Yu XJ, Nan KJ, Li EX, Liu JW, Gao YJ, Guan XQ, Song SP, Sheng LJ, Wang DL, Wang ZX. Wang ZP, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):468-70. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17152498 Clinical Trial. Chinese.

4

[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy].

Wang ZP, Sun Y, Zhang XR, Zhang MH, Wang XW, Yu XJ, Nan KJ, Li EX, Liu JW, Gao YJ, Guan XQ, Song SP, Sheng LJ, Wang DL, Wang ZX. Wang ZP, et al. Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):465-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024525 Clinical Trial. Chinese.

5

[Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma.].

Wang Y, Zhang X, Wang B, Wang Z, Chu D, Sun Y. Wang Y, et al. Among authors: wang z, wang b. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):137-41. doi: 10.3779/j.issn.1009-3419.2008.01.029. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727283 Free article. Chinese.

6

[Classification and regression tree analysis of 154 patients with cancer of unknown primary].

Wang ZP, Liu YT, Yang J. Wang ZP, et al. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):690-3. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122385 Chinese.

7

[Clinical report of combined chemotherapy with gemcitabine plus cisplatin as first-line treatment to 79 cases of advanced non-small cell lung cancer].

Lin L, Hao X, Li J, Wang Z, Wang Y, Wang H, Hu X, Zhang X. Lin L, et al. Among authors: wang h, wang z, wang y. Zhongguo Fei Ai Za Zhi. 2007 Dec 20;10(6):513-9. doi: 10.3779/j.issn.1009-3419.2007.06.14. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21129311 Free article. Chinese.

8

[Primary result of the efficacy and tolerance of gefitinib in advanced non-small cell lung cancer patients with brain metastasis].

Wang Y, Wang Y, Wang B, Wang Z, Zhang X, Chu D, Sun Y. Wang Y, et al. Among authors: wang z, wang b. Zhongguo Fei Ai Za Zhi. 2006 Oct 20;9(5):447-51. doi: 10.3779/j.issn.1009-3419.2006.05.12. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21176469 Free article. Chinese.

9

[Classification and regression tree analysis of clinical patterns that predict survival in 127 Chinese patients with advanced non-small cell lung cancer treated by gefitinib who failed to previous chemotherapy].

Wang Z, Guo J, Wang Y, Liu Y, Yang J. Wang Z, et al. Among authors: wang y. Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):699-703. doi: 10.3779/j.issn.1009-3419.2011.09.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21924034 Free PMC article. Chinese.

10

[Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer].

Zhao LD, Zhang XR, Li JL, Wang ZP, Wang Y, Hao XZ, Hu XS, Zhou SY, Sun Y, Shi YK. Zhao LD, et al. Zhonghua Yi Xue Za Zhi. 2012 Jun 12;92(22):1527-31. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22944054 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,178 results

Search Page

Filters